Why buy this course?

The course you are looking at is not like any other e-Learning course you have ever taken.
Watch this short video to learn why!

Benchmark: Medicare Drug Price Negotiation Program Final Rule: Compliance and Implementation

Take this benchmark to assess how much you would benefit from taking the course on the Medicare Drug Price Negotiation Program Final Rule.

This short pre-course check helps you gauge your readiness on policy intent, operational impact, equity and access, data readiness, and compliance risk under the new rule. The questions focus on trade‑offs and real‑world implications—not memorizing dates or definitions.

  • See your gaps fast: Identify where you may misjudge negotiation levers, formulary duties, biosimilar timing, or CMP risks.
  • Learn what matters most: Understand how the Maximum Fair Price (MFP) changes workflows, who benefits first, and where plans and manufacturers have to adapt.
  • Start implementation‑ready: Use your results to target the modules that turn policy into action—data submissions, stakeholder engagement, and point‑of‑sale execution.

By the end, you’ll know whether you need a quick refresher or the full course to confidently implement the rule and avoid costly missteps. Your answers won’t be graded—this is for your own calibration.

NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.

Federal Register Title
This benchmark will help determine your readiness for: Federal Register Document titled Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program. Document Number: 2026-22792

Buy this Course
FR-26-3315-1

About Benchmarks:

Are you ready for this regulation? Use this benchmark to find out.

Each benchmark is build directly for the federal regulation.  They reflect the learning objectives of the related course.

The benchmark is not a “trivia test” – they help you evaluate your readiness to apply the new regulation.

Contact us for more information and/or personalized benchmarks for your specific organization/industry.

Benchmark: Medicare Drug Price Negotiation Program Final Rule: Compliance and Implementation

Take this benchmark to assess how much you would benefit from taking the course on the Medicare Drug Price Negotiation Program Final Rule.

This short pre-course check helps you gauge your readiness on policy intent, operational impact, equity and access, data readiness, and compliance risk under the new rule. The questions focus on trade‑offs and real‑world implications—not memorizing dates or definitions.

  • See your gaps fast: Identify where you may misjudge negotiation levers, formulary duties, biosimilar timing, or CMP risks.
  • Learn what matters most: Understand how the Maximum Fair Price (MFP) changes workflows, who benefits first, and where plans and manufacturers have to adapt.
  • Start implementation‑ready: Use your results to target the modules that turn policy into action—data submissions, stakeholder engagement, and point‑of‑sale execution.

By the end, you’ll know whether you need a quick refresher or the full course to confidently implement the rule and avoid costly missteps. Your answers won’t be graded—this is for your own calibration.

NOTE: Unless otherwise indicated, all Benchmarks are free of charge!

Federal Register Title
This benchmark will help determine your readiness for: Federal Register Document titled Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program. Document Number: 2026-22792

Buy this Course
FR-26-3315-1

Replenish your Studio Course Advisor Unit balance here . Please contact frsales@courseavenue.com if you need to purchase more. Talk to use about an Enterprise License to see if that is right for you!

Benchmark: Medicare Drug Price Negotiation Program Final Rule: Compliance and Implementation

Federal Register Title
This benchmark will help determine your readiness for: Federal Register Document titled Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program. Document Number: 2026-22792

Buy this Course
FR-26-3315-1

Take this benchmark to assess how much you would benefit from taking the course on the Medicare Drug Price Negotiation Program Final Rule.

This short pre-course check helps you gauge your readiness on policy intent, operational impact, equity and access, data readiness, and compliance risk under the new rule. The questions focus on trade‑offs and real‑world implications—not memorizing dates or definitions.

  • See your gaps fast: Identify where you may misjudge negotiation levers, formulary duties, biosimilar timing, or CMP risks.
  • Learn what matters most: Understand how the Maximum Fair Price (MFP) changes workflows, who benefits first, and where plans and manufacturers have to adapt.
  • Start implementation‑ready: Use your results to target the modules that turn policy into action—data submissions, stakeholder engagement, and point‑of‑sale execution.

By the end, you’ll know whether you need a quick refresher or the full course to confidently implement the rule and avoid costly missteps. Your answers won’t be graded—this is for your own calibration.

Related products